GEE DAVID NICHOLAS 4
4 · Cellebrite DI Ltd. · Filed May 14, 2026
Research Summary
AI-generated summary of this filing
Cellebrite (CLBT) CMO David N. Gee Sells 228 Shares
What Happened David N. Gee, Chief Marketing Officer of Cellebrite DI Ltd. (CLBT), disposed of 228 shares on May 12, 2026. The shares were sold as reported on a Form 4 with a weighted average sale price of $13.01, producing proceeds of approximately $2,966. The transaction is reported as a sale (S) and is associated with tax obligations from previously granted restricted stock units (RSUs).
Key Details
- Transaction date: 2026-05-12; filed with the SEC on 2026-05-14 (appears timely — filed two days after the transaction).
- Quantity and price: 228 shares sold; weighted average price $13.01; actual sale prices ranged from $12.84 to $13.175.
- Proceeds: Approximately $2,966.
- Shares owned after transaction: Not reported in the supplied filing details.
- Notable footnotes:
- F1: The shares sold were issued as RSUs on February 11, 2025; the sale was made to cover tax obligations from RSU vesting.
- F2: The $13.01 price is a weighted average; the filer can provide a breakdown of the number of shares sold at each price within the $12.84–$13.175 range upon request.
Context This sale was tied to RSU vesting and related tax withholding rather than an indicated change in the executive’s view of the company; such filings that cover tax obligations are common. The filing shows an outright sale of vested shares rather than an option exercise or a gift. No indication of a 10% owner or a 10b5-1 plan was provided in the supplied data.
Insider Transaction Report
- Sale
Ordinary shares, par value NIS 0.00001
[F1][F2]2026-05-12$13.01/sh−228$2,966→ 147,705 total
Footnotes (2)
- [F1]The shares reported as disposed herein were granted on February 11, 2025, in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.84 to $13.175, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.